Medical/Pharmaceuticals
DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY
Debiopharm obtains global rights from Novo Nordisk for the development of their
ubiquitin-specific protease 1 (USP1) inhibitor
LAUSANNE, Switzerland, March 2, 2023 /PRNewswire/ -- Debiopharm (
www.debiopharm.com
2023-03-02 09:00
3885
ClinChoice Acquires CROMSOURCE, Expanding its Global Presence
PHILADELPHIA, SHANGHAI and VERONA, Italy, March 2, 2023 /PRNewswire/ -- ClinChoice Medical Development is pleased to announce its acquisition of CROMSOURCE S.r.l., an ISO-certified full-service contract research organization with its corporate headquarters inVerona, Italy and its US headquarters ...
2023-03-02 04:12
4884
AtomVie Global Radiopharma Inc. builds industry-leading radiopharmaceutical CDMO facility in Hamilton, Ontario
TORONTO, March 1, 2023 /PRNewswire/ -- AtomVie Global Radiopharma Inc. (AtomVie ) is pleased to announce the execution of a Lease Agreement with Panattoni Development Company inHamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated for high volum...
2023-03-01 22:00
2371
National Comprehensive Cancer Network Updates Annual Conference with New In-Person Venue, Hybrid Format, Expert-Led Sessions, Highlighted Research Perspectives, and Small-Group Conversations
Annual conference featuring more than a thousand worldwide oncology professionals will present new research findings, latest NCCN Guidelines updates, and best practices achieving quality cancer care delivery, inOrlando March 31—April 2, 2023. PLYMOUTH MEETING, Pa., March 1, 2023 /PRNewswire/ -- ...
2023-03-01 21:33
2273
Cambrex Recognized with CDMO Leadership Awards for 9th Consecutive Year
EAST RUTHERFORD, N.J., March 1, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it has been recognized with 2023 CDMO Leadership Awards in the categories of Quality, Service, Expertise, and Compatibility. Additionally...
2023-03-01 19:00
3358
Digital Transformation Across Life Sciences Industry Boosts Instrumentation Market
Automation and robotization to ensure industrywide streamlining and increase future growth potential SAN ANTONIO, March 1, 2023 /PRNewswire/ -- The development of next-generation sequencing (NGS) technology, a wide array of informatics, and robotics are some of the most recent technological adva...
2023-03-01 16:12
2627
A promising picture for multi-cancer early detection in Southeast Asia - latest update from biotech firm Gene Solutions
HO CHI MINH CITY, Vietnam, March 1, 2023 /PRNewswire/ -- In January 2023,
Vietnam's Medical Genetics Institute & Gene Solutions
2023-03-01 09:30
4114
AMPLIFY HEALTH ASIA PTE LIMITED APPOINTS DR AXEL BAUR AS CHIEF EXECUTIVE OFFICER
* Dr Axel Baur succeeds Dr Jonathan Broomberg as Chief Executive Officer in planned succession as Amplify Health Asia Pte Limited accelerates its commercial strategy inAsia Pacific * Dr Broomberg will reassume his role as CEO of Vitality Health International and Global Head of Health Insuranc...
2023-03-01 09:00
4065
Global Cold Chain Transport Track & Trace Revenues in Pharma to Reach US$2.9 billion by 2027
For pharmaceutical companies to ensure product integrity and maintain regulatory compliance, deeper product monitoring, enhanced cold chain infrastructure, and focused automation will be critical NEW YORK, Feb. 28, 2023 /PRNewswire/ -- The global pharmaceutical (pharma) industry will surpassUS$1...
2023-02-28 21:30
2382
JW Therapeutics Announces Initiation of Clinical Study of JWATM214 in Patients with Advanced Hepatocellular Carcinoma
SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the initiation of clinical study of JWATM214 in patients with advanced hepato...
2023-02-28 17:30
4189
Chula's AICute - An Assessment Tool for Ischemic Stroke Risk
A research team from the Faculty of Medicine and Faculty of Engineering, Chulalongkorn University has jointly developed AICute, an innovative program to assess the chance of stroke caused by heart disease (Ischemic Stroke), aimed at helping hospitals that lack cardiologists to enhance the effecti...
2023-02-28 12:24
4036
Pulnovo Medical Reports Positive One-year Results for PADN-CFDA Trial in Pulmonary Arterial Hypertension (PAH) Treatment
SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform, announced positive one-year results from the Pulmonary Artery Denervation (PADN)-CFDA pivotal study at the industry's most leading American Cardiovascular Research Technologies conference (CRT 202...
2023-02-28 10:19
2502
On Rare Disease Day 2023 RemeGen Highlights Its Social Responsibility and Rare Disease Advocacy
YANTAI, China, Feb. 28, 2023 /PRNewswire/ -- RemeGen Co., Ltd.
2023-02-28 09:16
4055
Over 90% of adults above the age of 50 carry the virus that causes shingles; yet only 3% of Singaporeans in this age group believe they are at high risk of developing the disease
GSK holds Shingles Awareness Week to educate Singaporeans about shingles and the importance of protection against it SINGAPORE, Feb. 28, 2023 /PRNewswire/ -- A GSK-sponsored Ipsos-MORI survey revealed only 3% of Singaporeans aged 50-79 years believe they are at high risk of developing shingles i...
2023-02-28 09:00
2657
CStone announces China's NMPA has accepted the supplementary new drug application of sugemalimab as first-line treatment for patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma
* This supplementary new drug application was filed for the fourth indication for sugemalimab inChina, following applications for stage III and stage IV non-small cell lung cancer and relapsed or refractory extranodal NK/T cell lymphoma. If approved, sugemalimab would be the first PD-L1 monoclo...
2023-02-28 08:05
6332
Innovent Announces First Participant Dosed in Phase 1 Clinical Study of IBI333 (VEGF-A/VEGF-C Bispecific Fusion Protein) in Patients with Neovascular Age-related Macular Degeneration
ROCKVILLE, Md. and SUZHOU, China, Feb. 28, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2023-02-28 08:00
5720
Everest Medicines Hosts Ceremony to Celebrate Commencement of Operations at its State-of-the-Art mRNA Vaccine Manufacturing Facility
SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today held a ceremony to celebrate the initiation of operations a...
2023-02-28 07:30
6772
Ascletis (1672.HK) Included in the Hang Seng Hong Kong-Listed Biotech Index
HANGZHOU and SHAOXING, China, Feb. 27, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it will be included in the Hang Seng Hong Kong-Listed Biotech Index (Index code: HSHKBIO), effective from March 13, 2023. HSHKBIO selects securities of multiple listed co...
2023-02-27 17:15
4658
Turacoz Paves the Way in Digital Content Management for Healthcare Communications with Veeva & Expert Training
UTRECHT, Netherlands and NEW DELHI, Feb. 27, 2023 /PRNewswire/ -- As digital
content gains importance in healthcare, the medical writing industry is
transitioning to digital content management.
2023-02-27 17:07
2424
Vieworks' VIVIX X-ray Flat Panel Detector Full Line-up to be Showcased at ECR 2023
ANYANG, South Korea, Feb. 27, 2023 /PRNewswire/ -- Vieworks, a leading global provider of high-performance digital x-ray imaging solutions, will be participating in the upcoming ECR 2023. Thousands of professionals from the medical imaging and healthcare industry will gather inVienna, Austria fro...
2023-02-27 17:00
4673
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 278 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 275 media titles]
2026-10-09 13:21DayOne Upsizes Malaysia Financing to US$7.2 Billion; Total Billings Surpass 1GW and Bookings Reach 2.3GW
[Picked up by 269 media titles]
2026-10-14 18:01Ampotech and Buskowitz Energy Collaborate to Deliver Integrated Energy Solutions Combining Energy Efficiency, Solar and Battery Storage
[Picked up by 263 media titles]
2026-10-14 09:30
Most Read
Nuix Neo Generative AI Framework
2026-10-08 08:02
15332
LEIFRAS Co., Ltd. Reports First Half of Fiscal Year 2026 Financial Results
2026-10-08 09:50
13390
XPENG G9L Completes First Production Trial in Europe
2026-10-08 07:33
12916
